1066vip威尼斯 - Apple App Store

Living standards of the general population have been improving. However, as life expectancy increases, so too does the incidence of chronic diseases. The incidence of hypertension, diabetes and coronary heart disease in China has been increasing every year, and has also led to subsequent increases in cardiovascular events, such as aortic dissection, pulmonary embolism and stroke. To combat this, emergency departments across the country have established chest pain centers, combining the emergency, cardiology and radiology department to optimize the treatment process of patients with chest pain.

What are Chest Pain Centers?

Chest pain centers are a multidisciplinary collaboration that aims to provide patients with chest pain with rapid and accurate diagnosis, risk assessment and appropriate treatment to improve early diagnosis and treatment of chest pain. It also aims to reduce cases of missed diagnosis or misdiagnosis of chest pain. Hospitals currently use the treatment process of direct percutaneous coronary intervention (PPCO), and a treatment system was established through the integration of medical resources to improve the treatment of patients with acute chest pain. To achieve this goal, China’s chest pain centers certification Standard consists of five major elements: basic conditions and qualifications, assessment and treatment of patients with acute chest pain, integration of pre-hospital emergency systems with in-hospital green pathways, training and education, and continuous improvement.

Basic components/requirements for chest pain centers:

1. Basic components for chest pain centers: Triage station, Acute chest pain clinic, treatment room and observation/waiting room.

2. Flow chart established outlining the rapid diagnosis and treatment of acute chest pain and the standardized diagnosis and treatment of acute coronary syndrome.

3. First ECG must be completed within 10 minutes of patient admission.

4. Biomarker tests, especially hypersensitive troponin must be done rapidly

5. Devices should be present to rapidly detect biomarkers (troponin and D-dimer) at the bedside, ensuring that blood is drawn in patient admission and that results are received within 20 minutes.

Five elements of China’s Chest Pain Center Certification Standard

1. Basic conditions and qualifications

The focus is on the ability to treat STEMI with emergency PCI

2. Assessment and treatment of patients with acute chest pain

Emphasis is on implementing ACS guidelines in clinical practice: streamlining guidelines.

3. Integration of the pre-hospital emergency system with the green channel in the hospital

The hospital must actively cooperate with the pre-hospital emergency system to shorten the treatment time.

4. Training and education

Coordinating all aspects of chest pain initial treatment to form a joint force.

5. Continuous improvement

Focus on shortening STEMI total ischemic time and to emphaasize step-by-step improvement.

ReLIA’s Chest Pain Centre Research center

1. The basic R&D center is located in Silicon Valley, California, USA, and the Asia Pacific Headquarters is located in the Shekou Free Trade Zone in Shenzhen. At present, the company has large-scale production bases and R&D centers in Shenzhen and Jiangsu. It has passed CFDA and ISO-13485 audit certification, and is mainly responsible for the assembly of production instruments and reagents in the United States.

2. The company's strong R&D team and capital investment, continuously introducing new technologies on a global scale, making diagnosis more accurate, making services more convenient, making medical more reliable, and further creating integrated medical and big data medical care.

3. Comprehensive and rapid detection system, the company has two series of bedside rapid detection systems: multi-functional immune detection system and immunofluorescence rapid detection system. The test covers hypersensitivity troponin (hs-cTnI), troponin (cTnI), N-terminal pro-brain natriuretic peptide (NT-proBNP) myoglobin (MYO), myeloperoxidase (MPO), muscle Rapid detection of cardiovascular diseases such as acid kinase isoenzyme (CK-MB), cardiac fatty acid binding protein (H-FABP), D-dimer (D-Dimer), procalcitonin (PCT), C-reactive protein (CRP) and other rapid detection of inflammation.

    

                

            American R&D Center         

    

    

                

            Shenzhen production base and R&D center         

    

    

                

            Jiangsu production base and R&D center